Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23237136 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged ≥75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI)
Condition: Platelet Reactivity
Interventions: Drug: Clopidogrel;   Drug: Prasugrel

Study has passed its completion date and status has not been verified in more than two years.